Özkan, E. et al. 2025. Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC. Radiology and Oncology. 59, 4 (Dec. 2025), 624–634.